
ZEVRA THERAPEUTICS, INC. — Investor Relations & Filings
Zevra Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and commercializing therapies for patients with rare diseases. The company focuses on addressing significant unmet medical needs by combining a data-driven scientific approach with a patient-first perspective. Its portfolio includes commercial products such as MIPLYFFA®, an FDA-approved treatment for Niemann-Pick disease type C (NPC), and OLPRUVA®. Zevra Therapeutics also maintains a late-stage clinical pipeline, specializing in advancing promising medicines that face complex clinical and regulatory challenges for conditions with limited or no available treatments.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-06-05 | English | |
| 10-Q - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-05-06 | English | |
| DEF 14A - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-04-20 | English | |
| 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer) | 2026-03-26 | English | |
| 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer) | 2026-03-19 | English | |
| 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-02-10 | English |
Browse filings by year
18 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 47983630 | 8-K | 2026-06-05 | English | ||
| 42027237 | 10-Q - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-05-06 | English | ||
| 34691421 | DEF 14A - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-04-20 | English | ||
| 33048522 | 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer) | 2026-03-26 | English | ||
| 32989270 | 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer) | 2026-03-19 | English | ||
| 32891827 | 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-02-10 | English | ||
| 32891826 | 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-02-04 | English | ||
| 32891828 | 4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Filer) | 2026-02-04 | English | ||
| 29766128 | 4 Filing | 2026-02-02 | English | ||
| 29766101 | 4 Filing | 2026-02-02 | English | ||
| 29766096 | 4 Filing | 2026-02-02 | English | ||
| 29766080 | 4 Filing | 2026-02-02 | English | ||
| 29766031 | 4 Filing | 2026-02-02 | English | ||
| 12217933 | FORM 4 | 2026-01-07 | English | ||
|
2025
1 filing
| |||||
| 12217935 | 8-K | 2025-12-17 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
GUANGDONG VTR BIO-TECH CO., LTD.
Researches and manufactures biological enzyme preparations …
|
300381 | CN | Manufacturing |
|
Guangdong Zhongsheng Pharmaceutical Co.,Ltd.
High-tech firm specializing in TCM, chemical drugs, and bio…
|
002317 | CN | Manufacturing |
|
Guangxi Wuzhou Zhongheng Group Co.,Ltd
Produces modernized TCM pharmaceuticals and health-oriented…
|
600252 | CN | Manufacturing |
|
Guangyuyuan Chinese Herbal Medicine Co.,Ltd.
Historic TCM producer of high-end herbal medicines using tr…
|
600771 | CN | Manufacturing |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Vertically integrated pharmaceutical enterprise manufacturi…
|
874 | CN | Manufacturing |
|
Guangzhou Innogen Pharmaceutical Group Co., Ltd.
Discovers and develops innovative therapies for metabolic a…
|
2591 | HK | Manufacturing |
|
Guangzhou LBP Medicine Science & Technology Co., Ltd.
Develops pathological diagnostic products and automated sys…
|
688393 | CN | Manufacturing |
|
GUANGZHOU WONDFO BIOTECH CO.,LTD
Develops and manufactures rapid diagnostic products and POC…
|
300482 | CN | Manufacturing |
|
Guerbet
Develops contrast media and medical devices for diagnostic …
|
GBT | FR | Manufacturing |
|
Gufic BioSciences Ltd.
Manufactures pharmaceutical formulations, APIs, and special…
|
GUFICBIO | IN | Manufacturing |
ZEVRA THERAPEUTICS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32811/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32811 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32811 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32811 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32811}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ZEVRA THERAPEUTICS, INC. (id: 32811)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.